237 related articles for article (PubMed ID: 19854471)
1. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
2. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
4. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
[TBL] [Abstract][Full Text] [Related]
5. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
6. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
7. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.
Lee RD; Barcel DA; Williams JC; Wang JG; Boles JC; Manly DA; Key NS; Mackman N
Thromb Res; 2012 Jan; 129(1):80-5. PubMed ID: 21737126
[TBL] [Abstract][Full Text] [Related]
8. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.
Auwerda JJ; Yuana Y; Osanto S; de Maat MP; Sonneveld P; Bertina RM; Leebeek FW
Thromb Haemost; 2011 Jan; 105(1):14-20. PubMed ID: 21057704
[TBL] [Abstract][Full Text] [Related]
9. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.
Khorana AA; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Lee AY
J Clin Oncol; 2017 Apr; 35(10):1078-1085. PubMed ID: 28029329
[TBL] [Abstract][Full Text] [Related]
10. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
11. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
12. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.
Delluc A; Rousseau A; Delluc C; Le Moigne E; Le Gal G; Mottier D; Van Dreden P; Lacut K
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):295-300. PubMed ID: 21372691
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
15. Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.
Kooiman J; den Exter PL; Kilicsoy I; Cannegieter SC; Eikenboom J; Huisman MV; Klok FA; Versteeg HH
J Thromb Thrombolysis; 2015 Oct; 40(3):323-30. PubMed ID: 25665657
[TBL] [Abstract][Full Text] [Related]
16. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
[TBL] [Abstract][Full Text] [Related]
17. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
18. Tumour and microparticle tissue factor expression and cancer thrombosis.
Date K; Hall J; Greenman J; Maraveyas A; Madden LA
Thromb Res; 2013 Feb; 131(2):109-15. PubMed ID: 23237339
[TBL] [Abstract][Full Text] [Related]
19. Annexin V
Chen Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Cao X; Zhang W; Liu L; Wu J
Clin Chim Acta; 2022 Nov; 536():169-179. PubMed ID: 36191610
[TBL] [Abstract][Full Text] [Related]
20. Tissue Factor-bearing MPs and the risk of venous thrombosis in cancer patients: A meta-analysis.
Cui CJ; Wang GJ; Yang S; Huang SK; Qiao R; Cui W
Sci Rep; 2018 Jan; 8(1):1675. PubMed ID: 29374212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
